Our Pipeline

Clinical FocusStage Development
DrugIndicationDiscoveryPreclinicalPhase 1Phase 2Phase 3
Fibrosis
BelapectinNASH Cirrhosis 
NASH Advanced Fibrosis 
Lung, Kidney 
Arrhythmia, Pulmonary Arterial Hypertension 
Cancer Immunotherapy (combination therapy)
Belapectin + KeytrudaMelanoma + Head/Neck Cancer 
Plaque Psoriasis
BelapectinModerate-severe 
Oral Galectin-3 Inhibitors
Discovery program to identify subcutaneous and oral forms of carbohydrates and oral small molecules 

Learn more about our development program here.

Galectin Therapeutics seeks to broaden the scope of galectin-related disease indications and science. Therefore, we have established a number of academic collaborations with investigators and welcome opportunities to work with additional investigators. Click here to contact us.